Management of Resistance to Tyrosine Kinase Inhibitors with Advanced Nanosystems


Combining complementarty, emerging, supra-disciplinary, technologies in nano-biotechnology NANORESISTANCE introduces an unprecedented integrated approach for the comprehensive management of failure to anti-cancer therapy and treatment monitoring.


The inter-sectoral mobility between academia and industry will be a priority as a means to improve cooperation between the two sectors and to eliminate cultural and other mobility barriers in the context of the “Innovation Union” flagship initiative. The vibrant inter-sectoral mobility program of NANORESISTANCE will play a structuring role by allowing researchers to acquire key skills which are equally relevant to the public and private sectors.

Important Dates

  • Kick-off Meeting, 23-24 January 2012, Nicosia, Cyprus
  • First Management Meeting and Self-Training, 3-5 March 2013, London, UK
  • Follow up Meeting and Training, 4-5 July, 2013, Athens, Greece
  • Advanced Summer School, 22-24 September 2013, Larnaca, Cyprus
  • NanoResistance IAPP Midterm Review, 25 September 2013, Larnaca, Cyprus
  • International Conference on Nanotheranostics (ICoN 2013), 26-28 September 2013, Larnaca, Cyprus


Post-doctoral job opportunities available now! ... more

Advanced Summer School and International Conference on Nanotheranostics (ICoN 2013) to be held in Larnace, September 22-28, 2013 ... more.

NANORESISTANCE Follow up Meeting and Training held in Athens, July 4-5, 2013 ... more

Management Meeting and Self-training for researchers and post graduates meeting held in London, March 3-5, 2013 .... more

Kick-off meeting was held in Nicosia, January 23-24/1/2012 ... more

  Funded by
Marie Curie Actions - Industry-Academia Partnerships and Pathways